APO RESEARCH · REPORT
0.9% Sodium Chloride Injection
0.9% Sodium Chloride Injection is a packaged sodium chloride solution for an identified medical-use specification.

Product & engineering
Understand the product.
Solution composition, container volume, closure, sterility assurance and labelled route of use define the supplied preparation. Container appearance does not establish clinical suitability or administration instructions.
The commercial boundary
The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.
Which preparation and packaging specification is being purchased?
Solution composition, container volume, closure, sterility assurance and labelled route of use define the supplied preparation. Container appearance does not establish clinical suitability or administration instructions.
Selected research
Market Structure
Global 0.9% Sodium Chloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global 0.9% Sodium Chloride Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for 0.9% Sodium Chloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for 0.9% Sodium Chloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for 0.9% Sodium Chloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for 0.9% Sodium Chloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of 0.9% Sodium Chloride Injection include Southwest Pharmaceutical Co., Ltd., Tonghua Golden-horse Pharmaceutical Industry Co.,ltd., Jiangsu Suzhong PHARMA Group Co., Ltd., Sichuan Kelun Pharmaceutical Co.,Ltd., Sichuan Biokin Pharmaceutical Co.,Ltd., SSY Group Limited, Shandong Weigao Pharmaceutical Co., Ltd., Novartis and Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global 0.9% Sodium Chloride Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of 0.9% Sodium Chloride Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents 0.9% Sodium Chloride Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 0.9% Sodium Chloride Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
0.9% Sodium Chloride Injection Segment by Company
Southwest Pharmaceutical Co., Ltd.
Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
Jiangsu Suzhong PHARMA Group Co., Ltd.
Sichuan Kelun Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd.
SSY Group Limited
Shandong Weigao Pharmaceutical Co., Ltd.
Novartis
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Jiangsu Sihuan Bioengineering Co.,Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
Jilin Province Dubang Pharmaceuticals Co., Ltd.
Pfizer
China Resources Double-crane Pharmaceutical Co.,Ltd.
Huaren Pharmaceutical Co.,Ltd.
Hebei TIANCHENG Pharmaceutical Co., Ltd.
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
Fresenius Kabi
CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
Cisen Pharmaceutical
PKU HealthCare Corp.,Ltd.
Baxter
Anhui Changjiang Pharmaceutical Co., Ltd.
Anhui Fengyuan Pharmaceutical Co.,Ltd.
Otsuka Pharmaceutical
BBraun
AstraZeneca plc.
Amphastar
0.9% Sodium Chloride Injection Segment by Type
100ml
250ml
500ml
Other
0.9% Sodium Chloride Injection Segment by Application
Hospitals
Clinics
Others
0.9% Sodium Chloride Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 0.9% Sodium Chloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 0.9% Sodium Chloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 0.9% Sodium Chloride Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the 0.9% Sodium Chloride Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 0.9% Sodium Chloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of 0.9% Sodium Chloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of 0.9% Sodium Chloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 100ml
- 250ml
- 500ml
- Other
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Southwest Pharmaceutical Co., Ltd.
- Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
- Jiangsu Suzhong PHARMA Group Co., Ltd.
- Sichuan Kelun Pharmaceutical Co.,Ltd.
- Sichuan Biokin Pharmaceutical Co.,Ltd.
- SSY Group Limited
- Shandong Weigao Pharmaceutical Co., Ltd.
- Novartis
- Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
- Jiangsu Sihuan Bioengineering Co.,Ltd.
- Jiangsu Hengrui Pharmaceuticals Co.,ltd.
- Jilin Province Dubang Pharmaceuticals Co., Ltd.
- Pfizer
- China Resources Double-crane Pharmaceutical Co.,Ltd.
- Huaren Pharmaceutical Co.,Ltd.
- Hebei TIANCHENG Pharmaceutical Co., Ltd.
- Hangzhou Minsheng Pharmaceutical Co., Ltd.
- Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
- Fresenius Kabi
- CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
- Cisen Pharmaceutical
- PKU HealthCare Corp.,Ltd.
- Baxter
- Anhui Changjiang Pharmaceutical Co., Ltd.
- Anhui Fengyuan Pharmaceutical Co.,Ltd.
- Otsuka Pharmaceutical
- BBraun
- AstraZeneca plc.
- Amphastar
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global 0.9% Sodium Chloride Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global 0.9% Sodium Chloride Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global 0.9% Sodium Chloride Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global 0.9% Sodium Chloride Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global 0.9% Sodium Chloride Injection Market Dynamics
- 2.1 0.9% Sodium Chloride Injection Industry Trends
- 2.2 0.9% Sodium Chloride Injection Industry Drivers
- 2.3 0.9% Sodium Chloride Injection Industry Opportunities and Challenges
- 2.4 0.9% Sodium Chloride Injection Industry Restraints
3 0.9% Sodium Chloride Injection Market by Manufacturers
- 3.1 Global 0.9% Sodium Chloride Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global 0.9% Sodium Chloride Injection Sales by Manufacturers (2021-2026)
- 3.3 Global 0.9% Sodium Chloride Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global 0.9% Sodium Chloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 0.9% Sodium Chloride Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global 0.9% Sodium Chloride Injection Manufacturers, Product Type & Application
- 3.7 Global 0.9% Sodium Chloride Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 0.9% Sodium Chloride Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 0.9% Sodium Chloride Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 0.9% Sodium Chloride Injection Tier 1, Tier 2, and Tier 3
4 0.9% Sodium Chloride Injection Market by Type
- 4.1 0.9% Sodium Chloride Injection Type Introduction
- 4.1.1 100ml
- 4.1.2 250ml
- 4.1.3 500ml
- 4.1.4 Other
- 4.2 Global 0.9% Sodium Chloride Injection Sales by Type
- 4.2.1 Global 0.9% Sodium Chloride Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global 0.9% Sodium Chloride Injection Sales by Type (2021-2032)
- 4.2.3 Global 0.9% Sodium Chloride Injection Sales Market Share by Type (2021-2032)
- 4.3 Global 0.9% Sodium Chloride Injection Revenue by Type
- 4.3.1 Global 0.9% Sodium Chloride Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global 0.9% Sodium Chloride Injection Revenue by Type (2021-2032)
- 4.3.3 Global 0.9% Sodium Chloride Injection Revenue Market Share by Type (2021-2032)
5 0.9% Sodium Chloride Injection Market by Application
- 5.1 0.9% Sodium Chloride Injection Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global 0.9% Sodium Chloride Injection Sales by Application
- 5.2.1 Global 0.9% Sodium Chloride Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global 0.9% Sodium Chloride Injection Sales by Application (2021-2032)
- 5.2.3 Global 0.9% Sodium Chloride Injection Sales Market Share by Application (2021-2032)
- 5.3 Global 0.9% Sodium Chloride Injection Revenue by Application
- 5.3.1 Global 0.9% Sodium Chloride Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global 0.9% Sodium Chloride Injection Revenue by Application (2021-2032)
- 5.3.3 Global 0.9% Sodium Chloride Injection Revenue Market Share by Application (2021-2032)
6 Global 0.9% Sodium Chloride Injection Sales by Region
- 6.1 Global 0.9% Sodium Chloride Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global 0.9% Sodium Chloride Injection Sales by Region (2021-2032)
- 6.2.1 Global 0.9% Sodium Chloride Injection Sales by Region (2021-2026)
- 6.2.2 Global 0.9% Sodium Chloride Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America 0.9% Sodium Chloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America 0.9% Sodium Chloride Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe 0.9% Sodium Chloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe 0.9% Sodium Chloride Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific 0.9% Sodium Chloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific 0.9% Sodium Chloride Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa 0.9% Sodium Chloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa 0.9% Sodium Chloride Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global 0.9% Sodium Chloride Injection Revenue by Region
- 7.1 Global 0.9% Sodium Chloride Injection Revenue by Region
- 7.1.1 Global 0.9% Sodium Chloride Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global 0.9% Sodium Chloride Injection Revenue by Region (2021-2026)
- 7.1.3 Global 0.9% Sodium Chloride Injection Revenue by Region (2027-2032)
- 7.1.4 Global 0.9% Sodium Chloride Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America 0.9% Sodium Chloride Injection Revenue (2021-2032)
- 7.2.2 North America 0.9% Sodium Chloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe 0.9% Sodium Chloride Injection Revenue (2021-2032)
- 7.3.2 Europe 0.9% Sodium Chloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific 0.9% Sodium Chloride Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific 0.9% Sodium Chloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa 0.9% Sodium Chloride Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa 0.9% Sodium Chloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Southwest Pharmaceutical Co., Ltd.
- 8.1.1 Southwest Pharmaceutical Co., Ltd. Company Information
- 8.1.2 Southwest Pharmaceutical Co., Ltd. Business Overview
- 8.1.3 Southwest Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Southwest Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.1.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
- 8.2 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
- 8.2.1 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Company Information
- 8.2.2 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Business Overview
- 8.2.3 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.2.5 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Recent Developments
- 8.3 Jiangsu Suzhong PHARMA Group Co., Ltd.
- 8.3.1 Jiangsu Suzhong PHARMA Group Co., Ltd. Company Information
- 8.3.2 Jiangsu Suzhong PHARMA Group Co., Ltd. Business Overview
- 8.3.3 Jiangsu Suzhong PHARMA Group Co., Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jiangsu Suzhong PHARMA Group Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.3.5 Jiangsu Suzhong PHARMA Group Co., Ltd. Recent Developments
- 8.4 Sichuan Kelun Pharmaceutical Co.,Ltd.
- 8.4.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
- 8.4.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Business Overview
- 8.4.3 Sichuan Kelun Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sichuan Kelun Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.4.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments
- 8.5 Sichuan Biokin Pharmaceutical Co.,Ltd.
- 8.5.1 Sichuan Biokin Pharmaceutical Co.,Ltd. Company Information
- 8.5.2 Sichuan Biokin Pharmaceutical Co.,Ltd. Business Overview
- 8.5.3 Sichuan Biokin Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sichuan Biokin Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.5.5 Sichuan Biokin Pharmaceutical Co.,Ltd. Recent Developments
- 8.6 SSY Group Limited
- 8.6.1 SSY Group Limited Company Information
- 8.6.2 SSY Group Limited Business Overview
- 8.6.3 SSY Group Limited 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 SSY Group Limited 0.9% Sodium Chloride Injection Product Portfolio
- 8.6.5 SSY Group Limited Recent Developments
- 8.7 Shandong Weigao Pharmaceutical Co., Ltd.
- 8.7.1 Shandong Weigao Pharmaceutical Co., Ltd. Company Information
- 8.7.2 Shandong Weigao Pharmaceutical Co., Ltd. Business Overview
- 8.7.3 Shandong Weigao Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Shandong Weigao Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.7.5 Shandong Weigao Pharmaceutical Co., Ltd. Recent Developments
- 8.8 Novartis
- 8.8.1 Novartis Company Information
- 8.8.2 Novartis Business Overview
- 8.8.3 Novartis 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Novartis 0.9% Sodium Chloride Injection Product Portfolio
- 8.8.5 Novartis Recent Developments
- 8.9 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
- 8.9.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
- 8.9.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Business Overview
- 8.9.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.9.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments
- 8.10 Jiangsu Sihuan Bioengineering Co.,Ltd.
- 8.10.1 Jiangsu Sihuan Bioengineering Co.,Ltd. Company Information
- 8.10.2 Jiangsu Sihuan Bioengineering Co.,Ltd. Business Overview
- 8.10.3 Jiangsu Sihuan Bioengineering Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Jiangsu Sihuan Bioengineering Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.10.5 Jiangsu Sihuan Bioengineering Co.,Ltd. Recent Developments
- 8.11 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
- 8.11.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
- 8.11.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Business Overview
- 8.11.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.11.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments
- 8.12 Jilin Province Dubang Pharmaceuticals Co., Ltd.
- 8.12.1 Jilin Province Dubang Pharmaceuticals Co., Ltd. Company Information
- 8.12.2 Jilin Province Dubang Pharmaceuticals Co., Ltd. Business Overview
- 8.12.3 Jilin Province Dubang Pharmaceuticals Co., Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Jilin Province Dubang Pharmaceuticals Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.12.5 Jilin Province Dubang Pharmaceuticals Co., Ltd. Recent Developments
- 8.13 Pfizer
- 8.13.1 Pfizer Company Information
- 8.13.2 Pfizer Business Overview
- 8.13.3 Pfizer 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Pfizer 0.9% Sodium Chloride Injection Product Portfolio
- 8.13.5 Pfizer Recent Developments
- 8.14 China Resources Double-crane Pharmaceutical Co.,Ltd.
- 8.14.1 China Resources Double-crane Pharmaceutical Co.,Ltd. Company Information
- 8.14.2 China Resources Double-crane Pharmaceutical Co.,Ltd. Business Overview
- 8.14.3 China Resources Double-crane Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 China Resources Double-crane Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.14.5 China Resources Double-crane Pharmaceutical Co.,Ltd. Recent Developments
- 8.15 Huaren Pharmaceutical Co.,Ltd.
- 8.15.1 Huaren Pharmaceutical Co.,Ltd. Company Information
- 8.15.2 Huaren Pharmaceutical Co.,Ltd. Business Overview
- 8.15.3 Huaren Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Huaren Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.15.5 Huaren Pharmaceutical Co.,Ltd. Recent Developments
- 8.16 Hebei TIANCHENG Pharmaceutical Co., Ltd.
- 8.16.1 Hebei TIANCHENG Pharmaceutical Co., Ltd. Company Information
- 8.16.2 Hebei TIANCHENG Pharmaceutical Co., Ltd. Business Overview
- 8.16.3 Hebei TIANCHENG Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Hebei TIANCHENG Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.16.5 Hebei TIANCHENG Pharmaceutical Co., Ltd. Recent Developments
- 8.17 Hangzhou Minsheng Pharmaceutical Co., Ltd.
- 8.17.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information
- 8.17.2 Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview
- 8.17.3 Hangzhou Minsheng Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Hangzhou Minsheng Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.17.5 Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments
- 8.18 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
- 8.18.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Information
- 8.18.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Business Overview
- 8.18.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.18.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments
- 8.19 Fresenius Kabi
- 8.19.1 Fresenius Kabi Company Information
- 8.19.2 Fresenius Kabi Business Overview
- 8.19.3 Fresenius Kabi 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Fresenius Kabi 0.9% Sodium Chloride Injection Product Portfolio
- 8.19.5 Fresenius Kabi Recent Developments
- 8.20 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
- 8.20.1 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Company Information
- 8.20.2 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Business Overview
- 8.20.3 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. 0.9% Sodium Chloride Injection Product Portfolio
- 8.20.5 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Recent Developments
- 8.21 Cisen Pharmaceutical
- 8.21.1 Cisen Pharmaceutical Company Information
- 8.21.2 Cisen Pharmaceutical Business Overview
- 8.21.3 Cisen Pharmaceutical 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.21.4 Cisen Pharmaceutical 0.9% Sodium Chloride Injection Product Portfolio
- 8.21.5 Cisen Pharmaceutical Recent Developments
- 8.22 PKU HealthCare Corp.,Ltd.
- 8.22.1 PKU HealthCare Corp.,Ltd. Company Information
- 8.22.2 PKU HealthCare Corp.,Ltd. Business Overview
- 8.22.3 PKU HealthCare Corp.,Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.22.4 PKU HealthCare Corp.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.22.5 PKU HealthCare Corp.,Ltd. Recent Developments
- 8.23 Baxter
- 8.23.1 Baxter Company Information
- 8.23.2 Baxter Business Overview
- 8.23.3 Baxter 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.23.4 Baxter 0.9% Sodium Chloride Injection Product Portfolio
- 8.23.5 Baxter Recent Developments
- 8.24 Anhui Changjiang Pharmaceutical Co., Ltd.
- 8.24.1 Anhui Changjiang Pharmaceutical Co., Ltd. Company Information
- 8.24.2 Anhui Changjiang Pharmaceutical Co., Ltd. Business Overview
- 8.24.3 Anhui Changjiang Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.24.4 Anhui Changjiang Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.24.5 Anhui Changjiang Pharmaceutical Co., Ltd. Recent Developments
- 8.25 Anhui Fengyuan Pharmaceutical Co.,Ltd.
- 8.25.1 Anhui Fengyuan Pharmaceutical Co.,Ltd. Company Information
- 8.25.2 Anhui Fengyuan Pharmaceutical Co.,Ltd. Business Overview
- 8.25.3 Anhui Fengyuan Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.25.4 Anhui Fengyuan Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 8.25.5 Anhui Fengyuan Pharmaceutical Co.,Ltd. Recent Developments
- 8.26 Otsuka Pharmaceutical
- 8.26.1 Otsuka Pharmaceutical Company Information
- 8.26.2 Otsuka Pharmaceutical Business Overview
- 8.26.3 Otsuka Pharmaceutical 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.26.4 Otsuka Pharmaceutical 0.9% Sodium Chloride Injection Product Portfolio
- 8.26.5 Otsuka Pharmaceutical Recent Developments
- 8.27 BBraun
- 8.27.1 BBraun Company Information
- 8.27.2 BBraun Business Overview
- 8.27.3 BBraun 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.27.4 BBraun 0.9% Sodium Chloride Injection Product Portfolio
- 8.27.5 BBraun Recent Developments
- 8.28 AstraZeneca plc.
- 8.28.1 AstraZeneca plc. Company Information
- 8.28.2 AstraZeneca plc. Business Overview
- 8.28.3 AstraZeneca plc. 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.28.4 AstraZeneca plc. 0.9% Sodium Chloride Injection Product Portfolio
- 8.28.5 AstraZeneca plc. Recent Developments
- 8.29 Amphastar
- 8.29.1 Amphastar Company Information
- 8.29.2 Amphastar Business Overview
- 8.29.3 Amphastar 0.9% Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.29.4 Amphastar 0.9% Sodium Chloride Injection Product Portfolio
- 8.29.5 Amphastar Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 0.9% Sodium Chloride Injection Value Chain Analysis
- 9.1.1 0.9% Sodium Chloride Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 0.9% Sodium Chloride Injection Production Mode & Process
- 9.2 0.9% Sodium Chloride Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 0.9% Sodium Chloride Injection Distributors
- 9.2.3 0.9% Sodium Chloride Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst